Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Anxiety, depression, and sleep disturbances among people on long-term efavirenz-based treatment for HIV: a cross-sectional study in Beijing, China

Fig. 3

Prevalence of neuropsychiatric adverse events and correlation between score of questionnaires and time on ART. Graphs show the prevalence of anxiety (a), depression (c) and sleep disturbances (e) in each group. Comparison among four groups was performed by chi-square test (or Fisher’s exact test where appropriate). Correlation between scores of HADS-A (b), HADS-D (d) and PSQI (f) and time on EFV-based ART respectively was performed by Spearman correlation analysis. p < 0.05 was considered statistically significant and a correlation coefficient > 0.3 was considered to be statistically correlated. Abbreviations: EFV, efavirenz; ART, antiretroviral therapy; HADS-A, anxiety scores of the Hospital Anxiety and Depression Scale; HADS-D, depression scores of the Hospital Anxiety and Depression Scale; PSQI, scores of the Pittsburgh Sleep Quality Index

Back to article page